The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Prosus NV
JSE:PRX
|
NL |
|
Omeros Corp
NASDAQ:OMER
|
US |
|
S
|
SEI Medical PCL
SET:SEI
|
TH |
|
D
|
Daebo Magnetic Co Ltd
KOSDAQ:290670
|
KR |
|
O
|
Oracle Corp
XMUN:ORC
|
US |
|
E
|
Encompass Health Corp
F:HSOA
|
US |
|
Industrial and Commercial Bank of China Ltd
OTC:IDCBF
|
CN |
|
Greenvale Energy Ltd
ASX:GRV
|
AU |
|
Vibrant Group Ltd
SGX:BIP
|
SG |
|
Abivax SA
NASDAQ:ABVX
|
FR |
|
Endesa SA
F:ENA
|
ES |
|
L
|
Lindblad Expeditions Holdings Inc
F:LI4
|
US |
|
I
|
Imperial Resources Inc
OTC:IPRC
|
US |
|
N
|
Nexgen Energy Ltd
NYSE:NXE
|
CA |
|
Atlanta Braves Holdings Inc
F:E45
|
US |
|
B
|
Barclays PLC
DUS:BCY
|
UK |
|
T
|
Tanaka Co Ltd
F:TDJ
|
JP |
|
K
|
Kirin Holdings Co Ltd
SWB:KIR
|
JP |
|
S
|
Sony Group Corp
F:SONA
|
JP |
|
S
|
Sankyo Co Ltd
F:SOK
|
JP |
|
K
|
Kajima Corp
SWB:KAJ
|
JP |
|
P
|
Photronics Inc
F:PQ2
|
US |
|
A
|
Asia Tele-Net and Technology Corporation Ltd
F:DKC
|
HK |
|
G
|
Grindr Inc
NYSE:GRND
|
US |
Prosus NV (PRX)’s 12-month stock price forecast through October 2027 has a consensus target of 113 443.54 Zac, implying 80% upside. The forecast is based on price targets from 21 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for
PRX is 113 443.54 Zac with a low forecast of 74 336.24 Zac and a high forecast of 154 560.49 Zac.
Over the last 8 years, the compound annual growth rate for Revenue has been 20%. The projected CAGR for the next 6 years is 14%.
Over the last 8 years, the compound annual growth rate for Gross Profit has been 22%. The projected CAGR for the next 5 years is 16%.
The compound annual growth rate for Operating Income over the next 6 years is 44%.
Over the last 8 years, the compound annual growth rate for Pre-Tax Income has been 0%. The projected CAGR for the next 3 years is 5%.
Over the last 8 years, the compound annual growth rate for Net Income has been 0%. The projected CAGR for the next 5 years is 4%.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
AI-generated answers can contain mistakes, outdated facts, or incomplete information. Always verify important details before making decisions.
The AI Assistant is designed for research and education. It does not provide personalized investment, legal, or tax advice.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more